TherapeuticsMD (TXMD) Leases: 2019-2025
Historic Leases for TherapeuticsMD (TXMD) over the last 6 years, with Sep 2025 value amounting to $5.5 million.
- TherapeuticsMD's Leases fell 12.49% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 12.49%. This contributed to the annual value of $6.1 million for FY2024, which is 11.22% down from last year.
- Per TherapeuticsMD's latest filing, its Leases stood at $5.5 million for Q3 2025, which was down 3.79% from $5.7 million recorded in Q2 2025.
- Over the past 5 years, TherapeuticsMD's Leases peaked at $9.2 million during Q1 2021, and registered a low of $5.5 million during Q3 2025.
- Its 3-year average for Leases is $6.5 million, with a median of $6.5 million in 2024.
- Data for TherapeuticsMD's Leases shows a maximum YoY fell of 15.89% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows TherapeuticsMD's Leases stood at $8.2 million in 2021, then decreased by 7.94% to $7.6 million in 2022, then declined by 9.33% to $6.9 million in 2023, then declined by 11.22% to $6.1 million in 2024, then dropped by 12.49% to $5.5 million in 2025.
- Its Leases stands at $5.5 million for Q3 2025, versus $5.7 million for Q2 2025 and $5.9 million for Q1 2025.